Gene: CCNT1

904
CCNT|CYCT1|HIVE1
cyclin T1
protein-coding
12q13.11-q13.12
Ensembl:ENSG00000129315 MIM:143055 Vega:OTTHUMG00000170393 UniprotKB:O60563
NC_000012.12
SNP Mapped
AD
0   
NA (AD)  NA (ND)   (Frontal_Cortex)
6.605e-1 (AD)  9.650e-1 (ND)

ANCO-SNPs

SNP ID Position Alleles Trait Variation Type
rs7297499chr12:48706067 (GRCh38.p7)T>Calcohol dependenceSNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
SEC24B0.91
AFF40.907
NUP1530.903
ATF60.901
SON0.892
ZNF7910.89
UBR50.89
CDK120.888
JMJD1C0.888
ANKHD10.885

Top 10 negatively co-expressed genes

Gene Symbol Pearson Correlation Coefficient
OR4F5-0.52
OR4F29-0.487
KLRC2-0.248
APOA1-0.244
NANOGNB-0.22
HES5-0.215
SPRR2A-0.193
SPRR2D-0.191
LCN1-0.183
HMHB1-0.183

Drugs/Compounds

    There is no DrugBank record for this gene !

ID Drug Name Action PubMed
C1202752-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone2-hydroxy-1-naphthylaldehyde isonicotinoyl hydrazone inhibits the reaction [CDK9 protein binds to CCNT1 protein]17631934
C0275764-hydroxy-2-nonenal4-hydroxy-2-nonenal results in decreased expression of CCNT1 mRNA12419474
D016604Aflatoxin B1Aflatoxin B1 results in increased methylation of CCNT1 gene27153756
D016604Aflatoxin B1Aflatoxin B1 results in increased expression of CCNT1 mRNA19770486
D000535Aluminum[APP protein modified form binds to Aluminum] which results in increased expression of CCNT1 mRNA21298039
D000638AmiodaroneAmiodarone results in increased expression of CCNT1 mRNA19774075
D003913DextroamphetamineDextroamphetamine affects the expression of CCNT1 mRNA12205029
D003913DextroamphetamineSOD1 affects the reaction [Dextroamphetamine affects the expression of CCNT1 mRNA]12205029
D0151237,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of CCNT1 mRNA"26238291
D001599BerberineBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D001599BerberineBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004958EstradiolEstradiol results in increased expression of CCNT1 mRNA23019147
C006780bisphenol Abisphenol A results in increased expression of CCNT1 mRNA25181051
D016572CyclosporineCyclosporine results in increased expression of CCNT1 mRNA25562108
C415250deferasiroxdeferasirox inhibits the reaction [CDK9 protein binds to CCNT1 protein]17631934
D002945Cisplatin[Cisplatin co-treated with jinfukang] results in decreased expression of CCNT1 mRNA27392435
D004026DieldrinDieldrin results in increased expression of CCNT1 mRNA23041725
D004040Dietary CarbohydratesBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D004040Dietary CarbohydratesBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004040Dietary CarbohydratesFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D004040Dietary CarbohydratesFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004040Dietary Carbohydratesrosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D004040Dietary Carbohydratesrosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004040Dietary Carbohydrates[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA20828602
D004040Dietary Carbohydrates[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein20828602
D004041Dietary FatsDietary Fats results in increased expression of CCNT1 mRNA25016146
D004041Dietary FatsBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D004041Dietary FatsBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004041Dietary FatsFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D004041Dietary FatsFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004041Dietary Fatsrosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D004041Dietary Fatsrosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D004041Dietary Fats[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA20828602
D004041Dietary Fats[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein20828602
C118739entinostatentinostat results in decreased expression of CCNT1 mRNA27188386
D011345FenofibrateFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D011345FenofibrateFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D006861Hydrogen PeroxideHydrogen Peroxide results in decreased expression of CCNT1 mRNA12419474
C492448ICG 001ICG 001 results in decreased expression of CCNT1 mRNA26191083
C544151jinfukang[Cisplatin co-treated with jinfukang] results in decreased expression of CCNT1 mRNA27392435
C544151jinfukangjinfukang results in decreased expression of CCNT1 mRNA27392435
D008070LipopolysaccharidesLipopolysaccharides results in decreased expression of CCNT1 mRNA12057914
D008627Mercuric ChlorideMercuric Chloride results in decreased expression of CCNT1 mRNA27188386
C004925methylmercuric chloridemethylmercuric chloride results in decreased expression of CCNT1 mRNA19465457
D008741Methyl MethanesulfonateMethyl Methanesulfonate results in increased expression of CCNT1 mRNA26011545
D009151Mustard GasMustard Gas results in increased expression of CCNT1 mRNA15674843
D037742Nanotubes, Carbon"Nanotubes, Carbon results in increased expression of CCNT1 mRNA"15585362
C086401pentabromodiphenyl etherpentabromodiphenyl ether analog results in increased expression of CCNT1 mRNA19095052
D010634PhenobarbitalPhenobarbital affects the expression of CCNT1 mRNA23091169
D010656PhenylephrinePhenylephrine inhibits the reaction [HEXIM1 protein binds to CCNT1 protein]17459355
C006253pirinixic acid[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCNT1 mRNA19710929
D010936Plant ExtractsPlant Extracts results in increased expression of CCNT1 mRNA23557933
C089730rosiglitazonerosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
C089730rosiglitazonerosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D013311StreptozocinBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D013311StreptozocinBerberine affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D013311StreptozocinFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D013311StreptozocinFenofibrate affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D013311Streptozocinrosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA]20828602
D013311Streptozocinrosiglitazone affects the reaction [[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein]20828602
D013311Streptozocin[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 mRNA20828602
D013311Streptozocin[Streptozocin co-treated with Dietary Carbohydrates co-treated with Dietary Fats] affects the expression of CCNT1 protein20828602
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin affects the expression of CCNT1 mRNA21570461
D013749Tetrachlorodibenzodioxin[Tetrachlorodibenzodioxin co-treated with TIPARP gene mutant form] results in decreased expression of CCNT1 mRNA25975270
D013749TetrachlorodibenzodioxinTetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CCNT1 protein]12917420
D013849ThimerosalThimerosal results in decreased expression of CCNT1 mRNA27188386
D014212TretinoinTretinoin results in increased expression of CCNT1 mRNA15753651
D014212TretinoinTretinoin results in increased expression of CCNT1 protein15753651
C012589trichostatin Atrichostatin A results in decreased expression of CCNT1 mRNA24935251
D014520UrethaneUrethane results in increased expression of CCNT1 mRNA28818685
D014635Valproic AcidValproic Acid results in decreased expression of CCNT1 mRNA23179753
D014635Valproic AcidValproic Acid affects the expression of CCNT1 mRNA17292431
D001335Vehicle EmissionsVehicle Emissions results in decreased methylation of CCNT1 gene25560391
C111237vorinostatvorinostat results in decreased expression of CCNT1 mRNA27188386
D015032ZincZinc deficiency results in increased expression of CCNT1 mRNA18356318

GO/Pathway

GO ID GO Term Qualifier Evidence PubMed
GO:0003677DNA binding-IDA16109376  
GO:0003682chromatin binding-IEA-  
GO:0004674protein serine/threonine kinase activity-TAS-  
GO:0005515protein binding-IPI9491887  9499409  10944537  12832472  12944466  15107825  
15563843  16135803  16601680  17289077  17690245  17724342  
18281698  18483487  18566585  19387490  19883659  19914168  
20153263  20535204  20562857  21729782  22190034  22959624  
23455922  23602568  26659056  
GO:0008134transcription factor binding-IPI25116364  
GO:0016538cyclin-dependent protein serine/threonine kinase regulator activity-IBA21873635  
GO:0019901protein kinase binding-IEA-  
GO:0044212transcription regulatory region DNA binding-IEA-  
GO:0070063RNA polymerase binding-IPI15563843  
GO:00973227SK snRNA binding-IDA11713533  
GO ID GO Term Qualifier Evidence PubMed
GO:0000079regulation of cyclin-dependent protein serine/threonine kinase activity-TAS9499409  
GO:0006366transcription by RNA polymerase II-TAS-  
GO:0006368transcription elongation from RNA polymerase II promoter-TAS-  
GO:0006468protein phosphorylation-IPI16109376  
GO:0007049cell cycle-IEA-  
GO:0016032viral process-IEA-  
GO:0042795snRNA transcription by RNA polymerase II-TAS-  
GO:0043923positive regulation by host of viral transcription-NAS25116364  
GO:0045737positive regulation of cyclin-dependent protein serine/threonine kinase activity-IBA21873635  
GO:0045944positive regulation of transcription by RNA polymerase II-IBA21873635  
GO:0045944positive regulation of transcription by RNA polymerase II-IDA15563843  
GO:0045944positive regulation of transcription by RNA polymerase II-TAS-  
GO:0050434positive regulation of viral transcription-TAS-  
GO:0051301cell division-IEA-  
GO:1900364negative regulation of mRNA polyadenylation-IMP19575011  
GO:1901409positive regulation of phosphorylation of RNA polymerase II C-terminal domain-IBA21873635  
GO ID GO Term Qualifier Evidence PubMed
GO:0000307cyclin-dependent protein kinase holoenzyme complex-IBA21873635  
GO:0005634nucleus-IBA21873635  
GO:0005634nucleus-IDA12944466  
GO:0005654nucleoplasm-IDA-  
GO:0005654nucleoplasm-TAS-  
GO:0005730nucleolusNOTIDA16109376  
GO:0008024cyclin/CDK positive transcription elongation factor complex-IDA9499409  15905409  
KEGG ID KEGG Term
Reactome ID Reactome Term Evidence
R-HSA-112382Formation of RNA Pol II elongation complex TAS
R-HSA-162582Signal TransductionTAS
R-HSA-162587HIV Life CycleIEA
R-HSA-162587HIV Life CycleTAS
R-HSA-162599Late Phase of HIV Life CycleIEA
R-HSA-162599Late Phase of HIV Life CycleTAS
R-HSA-162906HIV InfectionIEA
R-HSA-162906HIV InfectionTAS
R-HSA-162909Host Interactions of HIV factorsTAS
R-HSA-1643685DiseaseIEA
R-HSA-1643685DiseaseTAS
R-HSA-167152Formation of HIV elongation complex in the absence of HIV TatIEA
R-HSA-167169HIV Transcription ElongationTAS
R-HSA-167169HIV Transcription ElongationIEA
R-HSA-167172Transcription of the HIV genomeIEA
R-HSA-167172Transcription of the HIV genomeTAS
R-HSA-167200Formation of HIV-1 elongation complex containing HIV-1 TatTAS
R-HSA-167200Formation of HIV-1 elongation complex containing HIV-1 TatIEA
R-HSA-167238Pausing and recovery of Tat-mediated HIV elongationIEA
R-HSA-167243Tat-mediated HIV elongation arrest and recoveryIEA
R-HSA-167246Tat-mediated elongation of the HIV-1 transcriptTAS
R-HSA-167246Tat-mediated elongation of the HIV-1 transcriptIEA
R-HSA-167287HIV elongation arrest and recoveryIEA
R-HSA-167290Pausing and recovery of HIV elongationIEA
R-HSA-170834Signaling by TGF-beta Receptor ComplexTAS
R-HSA-176034Interactions of Tat with host cellular proteinsTAS
R-HSA-212436Generic Transcription PathwayTAS
R-HSA-2173793Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimerTAS
R-HSA-2173796SMAD2/SMAD3:SMAD4 heterotrimer regulates transcriptionTAS
R-HSA-3700989Transcriptional Regulation by TP53TAS
R-HSA-5663205Infectious diseaseIEA
R-HSA-5663205Infectious diseaseTAS
R-HSA-674695RNA Polymerase II Pre-transcription EventsTAS
R-HSA-6796648TP53 Regulates Transcription of DNA Repair GenesTAS
R-HSA-6807505RNA polymerase II transcribes snRNA genesTAS
R-HSA-6807505RNA polymerase II transcribes snRNA genesIEA
R-HSA-73857RNA Polymerase II TranscriptionTAS
R-HSA-73857RNA Polymerase II TranscriptionIEA
R-HSA-74160Gene expression (Transcription)TAS
R-HSA-74160Gene expression (Transcription)IEA
R-HSA-75955RNA Polymerase II Transcription ElongationTAS
R-HSA-8939211ESR-mediated signalingTAS
R-HSA-9006931Signaling by Nuclear ReceptorsTAS
R-HSA-9006936Signaling by TGF-beta family membersTAS
R-HSA-9018519Estrogen-dependent gene expressionTAS

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID Title (Year) Author Journal